The Correlation of Serum Adropin with Cardiovascular Risk Factors in the Experimental Rat Model of Chronic Kidney Disease and Its Implication in the Ameliorative Effect of Angiotensin-Converting Enzyme Inhibitors
Background: The risk of cardiovascular disease (CVD) in patients with chronic kidney disease (CKD) is estimated to be far greater than that in the general population. Adropin regulates endothelial function and may play a role in the pathogenesis of CVD. Angiotensin-converting enzyme inhibitor (ACEI)...
Saved in:
Main Authors: | Samaa Salah Abd-El-Fatah, Maha A. Fathy, Mohamed Ali Alabiad, Raja Aljafil, Mai Ahmed Gobran, Enssaf A. Ahmad, Ashwag S. Alsharidah, Mohammed Alorini, Sulaiman Mohammed Alnasser, Sara A. Awadh, Enas N. Morgan |
---|---|
Format: | Article |
Language: | English |
Published: |
Shiraz University of Medical Sciences
2024-12-01
|
Series: | Iranian Journal of Medical Sciences |
Subjects: | |
Online Access: | https://ijms.sums.ac.ir/article_50118_191421da601a0376a534b38f750c9927.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adropin: a key player in immune cell homeostasis and regulation of inflammation in several diseases
by: Junmin Wang, et al.
Published: (2025-01-01) -
Adropin as an indicator of T2DM and its complications
by: Hu Zhang, et al.
Published: (2022-11-01) -
Serum adropin levels as a potential biomarker for predicting diabetic kidney disease progression
by: I-Wen Chen, et al.
Published: (2025-02-01) -
Predictive biomarkers for cardiometabolic risk in postmenopausal women: insights into visfatin, adropin, and adiponectin
by: Anna Maria Cybulska, et al.
Published: (2025-02-01) -
Association between Mediterranean diet and metabolic health status among adults was not mediated through serum adropin levels
by: Maryam Shafiei, et al.
Published: (2025-01-01)